Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Dr. Martens plc
  6. Summary
    DOCS   GB00BL6NGV24

DR. MARTENS PLC

(DOCS)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
09/20/2021 09/21/2021 09/22/2021 09/23/2021 09/24/2021 Date
403(c) 402(c) 400.8(c) 400(c) 392(c) Last
694 898 609 265 690 065 295 054 722 226 Volume
+1.51% -0.25% -0.30% -0.20% -2.00% Change
More quotes
Estimated financial data (e)
Sales 2022 905 M 1 237 M 1 237 M
Net income 2022 158 M 216 M 216 M
Net Debt 2022 164 M 224 M 224 M
P/E ratio 2022 24,8x
Yield 2022 1,11%
Sales 2023 1 054 M 1 440 M 1 440 M
Net income 2023 189 M 258 M 258 M
Net Debt 2023 67,7 M 92,5 M 92,5 M
P/E ratio 2023 20,8x
Yield 2023 1,38%
Capitalization 3 920 M 5 359 M 5 359 M
EV / Sales 2022 4,51x
EV / Sales 2023 3,78x
Nbr of Employees 1 897
Free-Float 83,4%
More Financials
Company
Dr. Martens PLC, formerly Dr. Martens Limited, is a United Kingdom-based company that offers a footwear brand. The Company operates through three reporting segments: Europe, the MiddleEast and Africa (EMEA), Americas and Asia-Pacific (APAC). Its product categories include Originals, Fusion, Kids, Casual and Accessories. The Originals category comprises boots, shoes and loafers and also included within the Originals... 
Sector
Footwear
Calendar
12/09Earnings Release
More about the company
Ratings of Dr. Martens plc
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about DR. MARTENS PLC
08/02Certain Ordinary Shares of Dr. Martens plc are subject to a Lock-Up Agreement Ending on..
CI
07/29DR MARTENS : Revenue Soars 52% In Fiscal Q1
MT
07/29DR MARTENS : Earnings Flash (DOCS.L) DR. MARTENS Reports Fiscal Q1 Revenue GBP147.3M
MT
07/29Dr. Martens plc Reports Revenue Results for the First Quarter Ended June 30, 2021
CI
07/13DR MARTENS : Goldman Sachs Improves Dr. Martens Rating To Buy, Ups PT
MT
07/12Dr. Martens plc Announces Prior Year Quarterly Revenue Figures for the Year Ending 31 M..
CI
07/01Europe feasts on 'sublime' IPO bonanza in 2021. Is it getting bloated?
RE
06/28DR MARTENS : HSBC Upgrades Dr. Martens To Buy From Hold, Lifts PT
MT
06/21DR MARTENS : RBC Reduces Dr. Martens PT, Keeps Outperform Rating
MT
06/21DR. MARTENS PLC(LSE : DOCS) added to FTSE All-World Index
CI
06/17DR MARTENS : Goldman Sachs Raises Of Dr. Martens PT, Keeps Neutral Rating
MT
06/17DR MARTENS : says brand's strength helped it during pandemic
RE
06/17DR MARTENS : FY21 Profit Drops 52% On IPO Costs
MT
06/17DR MARTENS : says brand's strength helped it during pandemic
RE
06/17DR MARTENS : Earnings Flash (DOCS.L) DR. MARTENS Posts FY21 Revenue GBP773M
MT
More news
News in other languages on DR. MARTENS PLC
06/30ÜBERBLICK/Anstehende Indexänderungen
06/295 sociétés avec une marque forte
06/28ÜBERBLICK/Anstehende Indexänderungen
06/21ÜBERBLICK/Anstehende Indexänderungen
06/18PUMP / DUMP #16á : Les Tops & Flops de la semaine
More news
Analyst Recommendations on DR. MARTENS PLC
More recommendations
Chart DR. MARTENS PLC
Duration : Period :
Dr. Martens plc Technical Analysis Chart | DOCS | GB00BL6NGV24 | MarketScreener
Technical analysis trends DR. MARTENS PLC
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 392,00 GBX
Average target price 519,38 GBX
Spread / Average Target 32,5%
EPS Revisions
Managers and Directors
Kenneth Charles Wilson Chief Executive Officer & Director
Jon William Mortimore Chief Financial Officer & Director
Paul Mason Chairman
Ronald Garricks Chief Information Officer
Geert Raymond Peeters Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
DR. MARTENS PLC0.00%5 494
PUMA SE7.26%17 923
DECKERS OUTDOOR CORPORATION35.56%11 812
CROCS, INC.160.13%10 169
ALPARGATAS S.A.36.00%5 687
RELAXO FOOTWEARS LIMITED43.25%3 946